While new lending facilities target a broader range of businesses and have fewer restrictions on private equity backing, they still leave a lot to be desired.
LP investors are taking to heart lessons from previous downturns as they evaluate their private equity commitments and chart a path forward.
Health care remains an active sector for middle-market leveraged finance, with interest spread across a broad spectrum of subsectors.
The evolving legal landscape and maturation of the cannabis industry have generated new interest and raised questions about where and when PE firms can get involved.
As middle-market dealmaking has slowed drastically, private equity and investment banking firms are in need of evolved approaches to business development, marketing and communications.